Notably, tirzepatide (Zepbound) was not approved for weight management in patients with overweight or obesity until shortly before the patient-identification window closed, resulting in most patients in the tirzepatide cohort receiving Mounjaro, which was assumed to be used off-label for chronic weight management in the absence of T2DM
Cc nghin cu tin lm sng cho thy tim nng ca n trong vic thc y qu trnh cha lnh cc chn thng c xng nh gy xng, t gn, rch dy chng v chn thng c
Part of that would be making sure every patient seeking a GLP-1 drug is screened for an eating disorder and monitored to ensure theyre eating enough, maintaining their health, and not losing weight too quickly
Ageing Res
The findings derive from laboratory research and do not describe or imply any effect, benefit, or use in humans or animals
It's unknown whether tirzepatide passes into breast milk and is harmful to your baby